BioNTech: Though Q1 operations missed expectations, 2026 guidance remained unchanged
Earnings/Sales Releases
BioNTech's Q1 performance did not meet expectations, with Operating Losses exceeding forecasts. Despite this, 2026 Guidance remains unchanged. Although the co-founders'...